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Zinc is essential for function of mitochondria as a cofactor for
several matrix zinc metalloproteins. We demonstrate that a
labile cationic zinc component of low molecular mass exists in
the yeast mitochondrial matrix. This zinc pool is homeostatically regulated in response to the cellular zinc status. This pool
of zinc is functionally important because matrix targeting of a
cytosolic zinc-binding protein reduces the level of labile zinc
and interferes with mitochondrial respiratory function. We
identified a series of proteins that modulate the matrix zinc
pool, one of which is a novel conserved mitochondrial protein
designated Mzm1. Mutant mzm1⌬ cells have reduced total and
labile mitochondrial zinc, and these cells are hypersensitive to
perturbations of the labile pool. In addition, mzm1⌬ cells have a
destabilized cytochrome c reductase (Complex III) without any
effects on Complexes IV or V. Thus, we have established that a
link exists between Complex III integrity and the labile mitochondrial zinc pool.

All known mitochondrial zinc-requiring metalloproteins
are synthesized in the cytoplasm and must be imported as
newly synthesized polypeptides into the organelle as with
most resident proteins. Protein import into the mitochondria requires unfolded polypeptides, so folding and metallation
occur upon import. Thus, a bioavailable pool of Zn(II) must be
maintained within the mitochondria for efficient metallation
reactions. The folding of metalloproteins is dependent on the
availability and the selective insertion of the appropriate metal
ion. Mis-metallation by a non-native metal ion may be deleterious yielding either an inactive protein or a misfolded state
prone to aggregation.
The zinc mitochondrial metalloproteome is large relative to
other metals and distributed throughout the organelle (1). The
zinc proteome is heavily populated by proteases and in yeast
include the iAAA, mAAA, Oma1, Oct1, Icp55, Atp23, and the
MPP protease complex. These proteases all share an essential
HEXXH or HXXEH metal-binding motif and whereas many
metalloproteinases can be activated in vitro by diverse divalent
cations, Zn(II) is likely to be the physiological metal ion bound.
Zn(II) is an abundant cofactor for a variety of additional
metalloenzymes in mitochondria, including Adh3, Adh4, and
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Leu9 in the matrix, in addition to Cu,Zn Sod1 and Hot13 in the
IMS (2). Last, cytochrome c oxidase requires Zn(II) in its Cox4
subunit (3).
Cellular Zn(II) acquisition in eukaryotes is achieved through
a conserved ZIP (or SLC39) family of transporters (4). ZIP
transporters in yeast (Zrt1 and Zrt2) and mammals predominately translocate Zn(II) from the extracellular space or
organelles into the cytoplasm. A second class of eukaryotic
Zn(II) transporters is the cation diffusion facilitator (CDF, ZnT,
or SLC30) family that typically translocate Zn(II) from the cytoplasm either into organelles or out of the cell (4, 5). Both families of transporters are polytopic intrinsic membrane proteins.
Fourteen candidate ZIP and ten distinct ZnT transporters are
known in the human genome, whereas yeast possess five ZIP
and five CDF transporters (6). Zn(II) transporters have been
identified that mediate Zn(II) uptake into the ER, Golgi, and
vacuole compartments (4), although no ZnT or ZIP mitochondrial transporters have been identified.
Within eukaryotic cells, labile Zn(II) pools have been identified using Zn(II)-responsive fluorophores (7, 8). Punctate fluorescent components seen in a myriad of cell types have been
termed zincosomes (9), although the compartment has not
been fully defined (4). Labile Zn(II) pools have been described
in the brain, pancreas, prostate, and the retina. The correlation
of the cellular fluorescence with labile Zn(II) pools is complicated by caveats such as the binding affinity of the fluorophore,
discrimination among diverse metal ions, and a tendency of
fluorophores to compartmentalize. Nonetheless, the visualization of labile Zn(II) pools with fluorophores of varying Zn(II)
binding affinities suggests that cells contain pools of kinetically
labile, ligand-bound Zn(II) (9).
One defined labile Zn(II) pool resides in presynaptic boutons
in mossy fiber neurons within the hippocampus (7). These presynaptic vesicles are also enriched with glutamate as a neurotransmitter. The vesicles accumulate Zn(II) to ⬃0.3 mM
through the ZnT-3 Zn(II) transporter (10 –12). Synaptic cleft
Zn(II) is a modulator of glutamate receptors and post-synaptic
neuronal Zn(II) may have a second messenger effect.
Labile Zn(II) is also seen in secretory granules in pancreatic ␤
cells, mast cells, intestinal paneth cells, and prostate epithelial
cells (8). Ligands stabilizing the labile Zn(II) pools have not
been defined, although the presence of high citrate in prostate
secretory granules and glutamate in mossy fiber neuronal granules suggest that these compounds may stabilize Zn(II).
Labile Zn(II) pools have also been observed within mitochondria. A labile mitochondrial Zn(II) pool distinct from protein-bound Zn(II) was identified using the mitochondrial-speVOLUME 285 • NUMBER 25 • JUNE 18, 2010
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cific Zn-responsive fluorophore RhodZin-3 in neuronal cells
(13, 14). The labile pool was shown to be dependent on the IM
membrane potential and to be mobilized upon mitochondrial
depolarization. No information exists on the ligands that stabilize labile Zn(II) in mitochondria nor the effects of zinc status
on this pool.
We describe presently the identification of a labile Zn(II)
pool within yeast mitochondria that is responsive to the exogenous Zn(II) level. High throughput screens were conducted to
identify proteins important for the maintenance of the mitochondrial labile Zn(II) pool. One protein identified, Mzm1, was
found to be important for both the maintenance of matrix zinc
and assembly/stability of the respiratory Complex III. These
studies establish a link between Complex III and mitochondrial
zinc pools.

MATERIALS AND METHODS
Yeast Strains and Media—BY4741 and BY4743 strains
deleted for mzm1⌬, cit1⌬, mis1⌬, mdh1⌬, msb1⌬, nfu1⌬, and
tbs1⌬ were purchased from Invitrogen and verified with openreading frame (ORF)3-specific PCR primers. Disruption of
MZM1 in the W303 background was accomplished by substituting the Candida albicans URA3 coding sequence. A 13Myc
epitope was fused to the 3⬘ of the chromosomal-encoded
MZM1 ORF (Mzm1-Myc) in the W303 background. EDTA
supplementation (1 mM final concentration) to liquid synthetic
complete medium was used to limit Zn availability for wild-type
cells. Lower levels of EDTA were used with mutant strains
when necessary. Strains were subsequently grown by serial
dilutions on plates with EDTA supplementation adjusted as
needed between 50 and 300 M. For large scale m-Adh1 limitation of mitochondrial zinc, cells were grown in glassware
washed with acid (5% nitric acid, 1% HCl) using culture
medium made with yeast nitrogen base lacking Zn salts. For the
EDTA-based robotic screen, 0.2– 0.5 mM EDTA supplementation was added to non-fermentable glycerol medium. Standard
synthetic complete medium was used in all other screens.
Expression Vectors—A pVT102-based Adh1::HA expression
clone (herein referred to as c-Adh1) utilizing the minimal, nonzinc regulated ADH1 promoter was constructed by Dr.
Amanda Bird. To target c-Adh1 to the mitochondrial matrix,
the targeting sequence from Sod2 was fused to the ADH1 ORF
using mega-primer PCR and gap-repair, herein referred to as
m-Adh1. Similarly the catalytically inactive m-Adh1 was generated by an alanine substitution of a critical threonine at position 48 (15) by overlap extension PCR.
Robotic Screen—A collection consisting of deletion strains of
684 nuclear-encoded genes whose products were identified in a
survey of the yeast mitochondrial proteome was arrayed in a
96-well format. Growth was tested using robotically applied
serial dilutions of the strains on non-fermentable medium supplemented with 0.4 mM EDTA. Similarly, the strain collection
was transformed with m-Adh1 (T48A) and screened for candidates showing m-Adh1-dependent growth inhibition on nonfermentable medium.
3

The abbreviations used are: ORF, open-reading frame; ICP, inductively coupled plasma; BN, blue native; HA, hemagglutinin; WT, wild type.

JUNE 18, 2010 • VOLUME 285 • NUMBER 25

Preparation of Mitochondria—Mitochondria were isolated
as described previously (16). Briefly, lyticase was used to create
spheroplasts that were subsequently ruptured by vortexing
with glass beads or Dounce homogenizing for protein localization experiments. Intact mitochondria were purified from the
cellular lysate using differential centrifugation and a discontinuous Nycodenz gradient (14 and 22%). Mitochondria were then
centrifuged at 12,000 ⫻ g to concentrate before analysis. Protein concentrations were determined using standard Bradford
protein reagents.
Mitochondrial Fractionation—To isolate submitochondrial
fractions, the outer membrane was lysed in 10 mM Tris-HCl, pH
7.4 (or 20 mM HEPES, pH 7.2 for protein localization experiments), and the lysate subsequently centrifuged at 25,000 ⫻ g to
separate the soluble IMS contents from mitoplasts retaining
matrix contents in the pellet fraction. To isolate soluble matrix
contents, mitoplasts were sonicated and again centrifuged at
25,000 ⫻ g to separate soluble matrix contents from the membrane fraction in the pellet. For batch-binding experiments,
either hydrated carboxymethyl cellulose 52 (CM-52) or
DEAE-52 ion exchange resins (Whatman) were added to soluble mitochondrial lysate at 4 °C with elution in 1 M ammonium
acetate, pH 7.4, when needed. For fractionation of mitochondrial Zn, whole mitochondria were lysed by sonication in buffer
A (20 mM ammonium acetate pH 7.4) using three 30-s pulses of
sonication at 70% output of a microtip. The soluble fraction was
then isolated by centrifugation at 15,000 ⫻ g. The soluble fraction was further diluted into buffer A, filtered through a 0.45 M
filter and injected onto either pre-equilibrated HR5/5 MonoQ
or MonoS columns. The unbound fractions were washed off
with 5 column volumes of buffer A. A 25–35 column-volume
gradient of buffer B (1 M ammonium acetate, pH 7.4) was then
initiated. Treatments of mitochondrial Zn samples, or free zinc
controls were as follows: soluble mitochondrial lysate was
boiled for 5 min and clarified by centrifugation 15,000 ⫻ g
prior to injection; for citrate competition experiments, a
10-fold excess of citrate was mixed with either a MonoSprepurified Zn-ligand sample or buffered free Zn and immediately injected onto MonoS and fractionated as above. For
size exclusion chromatography, concentrated cationic fractions were injected on a Sephadex G-25 column pre-equilibrated in 2⫻ phosphate-buffered saline. Fractions were collected and analyzed either by atomic absorption or inductively
coupled plasma (ICP) spectroscopy.
Western Blot and Blue Native (BN) PAGE Analysis—For
Western blot analysis, 20 –50 g of total protein from mitochondria was separated on a 12% SDS-PAGE gel system and
transferred onto nitrocellulose membranes for analysis. Membranes were blocked prior to detection using 10% nonfat dry
milk in 1⫻ PBS (50 mM Na2PO4, 100 mM NaCl2), and 0.01%
Tween 20. BN-PAGE was done essentially as described previously (17) with either 1% digitonin or 1% dodecylmaltoside used
to solubilize samples. Blots were reprobed after stripping in 3–5
washes of 25 mM glycine pH 2.0, 100 mM NaCl2, and 0.5%
Tween 20. Antibodies to porin (Por1), hemagglutinin (HA),
phosphoglycerate kinase 1 (Pgk1) were obtained from Molecular Probes. Cox1, Cox2, and Cox3 antibodies were purchased
from Mitosciences. Antisera to mitochondrial aconitase (Aco1)
JOURNAL OF BIOLOGICAL CHEMISTRY
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was a gift from Dr. J. Kaplan. Antisera to the Rieske iron sulfur
protein (Rip1) was a gift from Dr. B. Trumpower. Antisera to
cytochrome 1 (Cyt1) was a gift from Dr. B. Meunier. Antisera to
cytochrome b2 was provided by Dr. C. Koehler. Anitsera to the
F1 ATPase beta subunit (Atp2) and core protein 2 (Cor2) were
provided by Dr. A. Tzagoloff.
Metal Analysis—For ICP-OES mitochondria, were resuspended in 200 l of metal-free 40% nitric acid (Optima) and
heated to 95 °C for 2 min. Soluble fractions were read directly
after dilution with 10% nitric acid. Volumetric serial dilutions of
commercially available mixed metal standards were used to
generate standard curves. For Atomic Absorption Spectroscopy, soluble fractions were compared with suitable blank readings and concentrations calculated from ICP-verified standards. The Zn-dependent fluorophore, RhodZin-3 dipotassium
salt (Molecular Probes) was used to assess labile zinc concentrations. Either submitochondrial fractions, or soluble mitochondrial contents from 20 –100 g of total mitochondria sonicated in cold 10 mM Tris, pH 7.4, were analyzed in triplicate.
Samples were diluted 1:5 in cold 30 – 60 M RhodZin-3, 10 mM
Tris, pH 7.4, and allowed to incubate for 30 s prior to measuring
maximal emission at 575 nm (excitation at 535 nm) on a Perkin
Elmer SS55 fluorimeter.
Measurement of Mitochondrial Respiration—Oxygen consumption by cells grown to stationary phase and then diluted to
an A600 of 0.5 in 3 ml of 5% glycerol was determined using a
5300A biological oxygen monitor (Yellow Springs Instrument
Co.). Activities of the respiratory complexes were measured as
previously reported using 10 –20 g of mitochondria in 40 mM
KH2PO4 pH 6.7, 0.5% Tween 20 with 32 M horse cytochrome
c (18). Cytochrome c was chemically reduced using sodium
hydrosulfite for Complex IV activities; to measure the coupled
Complex II/III activity cytochrome c reduction was monitored
upon succinate addition in the presence of KCN to inhibit
Complex IV. For Complex III measurements, the reduction of
bovine cytochrome c was measured using the same buffer system and KCN inhibition as above. Complex III was directly
reduced by 20 M of the reduced ubiquinone analog, decylubiquinone (Sigma). Reduced decylubiquinone was prepared
anaerobically using saturated sodium borohydride. Excess
borohydride was later reacted with 6 N HCl while venting to
allow release of hydrogen gas. Any precipitates in the reduced
decylubiquinone were spun down and the solution transferred
to a fresh vial under nitrogen. The decylubiquinone concentration was determined on a pre-reduced aliquot using the molar
extinction coefficient (⑀) of 12.5 mM⫺1 cm⫺1 at 275 nM.

RESULTS
Distribution of Zn within Mitochondria—The zinc content of
gradient-purified mitochondria was assessed in cells cultured
in YPD (1% dextrose) medium in the presence and absence of
supplemental ZnCl2. The Zn content was found to be maintained at a nearly constant value until supplemental zinc levels
exceeded 200 M, at which point an expansion in mitochondrial zinc content was observed (Fig. 1A). To assess the distribution of zinc within mitochondria, purified and sonicated
mitochondria were fractionated into soluble and particulate
(pellet) fractions and subjected to ICP-OES analysis. As can be

19452 JOURNAL OF BIOLOGICAL CHEMISTRY

seen in Fig. 1B, Zn(II) was equally distributed between these
fractions in mitochondria from cells cultured in unsupplemented YPD medium. Mitochondria from cells supplemented
with 200 M Zn(II) contain a 3-fold expansion of total zinc that
was also equally distributed between soluble and particulate
fractions. The soluble fractions from Zn-supplemented and
unsupplemented cells were further fractionated by adsorption
to DEAE- or CM-cellulose to isolate their cationic and anionic
components, respectively. Zn(II) was similarly distributed
between cationic and anionic pools in mitochondria from zincsupplemented and unsupplemented cells. Cationic and anionic
Zn(II) fractions obtained from unsupplemented cultures were
incubated with the Zn-responsive RhodZin-3 fluorophore (Fig.
1C). The fluorescence of the cationic Zn fraction significantly
exceeded that of the anionic Zn fraction despite having a similar
zinc concentration suggesting that the cationic Zn fraction possessed greater kinetic reactivity.
The soluble mitochondrial lysates isolated from control and
Zn-supplemented cells were adsorbed to MonoS and MonoQ
ion exchange resins to further fractionate the cationic and anionic pools, respectively (Fig. 1, D and F). MonoS and MonoQ
columns were eluted with a gradient of ammonium acetate. A
major Zn-containing fraction was observed in the eluate of
each exchanger, and the abundance of each component was
increased in mitochondria isolated from Zn-supplemented
cells. To assess the nature of the Zn component in the eluate of
each exchanger, the mitochondrial lysate isolated from Zn-supplemented cells was first pretreated by boiling prior to the chromatography. Whereas the Zn component in the MonoQ eluate
was depleted by boiling, the Zn component in the MonoS
eluate was largely stable (Fig. 1, D and F). The MonoS Zn
component was also resistant to proteinase K digestion suggesting that the MonoS Zn component is not protein bound
(data not shown). To determine whether this cationic Zn component represents unbound Zn(II), both ZnCl2 and the purified
cationic Zn complex were incubated with citrate prior to
MonoS chromatography. As shown in Fig. 1E, the elution position of the cationic Zn component was unchanged, whereas
no Zn(II) was seen in the eluate during chromatography of a
preformed Zn-citrate complex. The cationic Zn complex
eluted from Sephadex G-25 near the internal volume consistent with a low mass Zn(II) complex (Fig. 1G). These data
indicate that the cationic pool of labile zinc in the mitochondrial matrix is largely complexed with one or more compounds of low molecular mass. We will refer to this labile zinc
pool as the cationic zinc pool because it adsorbs on cation
exchangers and appears to be a monodisperse component.
Effect of a Heterologous Zn Competitor on Mitochondrial Zn
Distribution—We previously demonstrated that the bioavailable
Cu(I) pool in yeast mitochondria was titrated out by the presence
of heterologous Cu(I)-binding proteins targeted to the mitochondrial matrix (19, 20). To determine whether a similar situation
existed with the mitochondrial Zn fractions, we fused the Sod2
mitochondrial targeting sequence (MTS) to the cytoplasmic Adh1
molecule, designated m-Adh1, resulting in mitochondrial localization (Fig. 2A). Two m-Adh1 constructs were engineered. One
fusion was the WT Adh1 sequence, whereas the second fusion was
a catalytically inactive Adh1 allele (T48A). Yeast containing the
VOLUME 285 • NUMBER 25 • JUNE 18, 2010
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Mitochondria were purified from
yeast transformants to assess mitochondrial zinc levels. Mitochondria
isolated from m-Adh1 cells cultured
in standard complete medium exhibited a marked increase in mitochondrial Zn (Fig. 2D) and chromatography of soluble lysates on MonoS
revealed a comparable level of the cationic Zn component in the elution
gradient, whereas elevated Zn(II) was
detected in the column wash fractions. Treatment of the soluble lysate
with RhodZin-3 revealed no change
in fluorescence in lysates isolated
from c-Adh1 mitochondria versus
m-Adh1 mitochondria (Fig. 2D, right
panel). Thus, the presence of m-Adh1
in the mitochondria of cells propagated on synthetic complete growth
medium leads to an expansion of the
mitochondrial zinc content to
accommodate the high Adh1 levels.
This is further evidence of homeostatic control of the mitochondrial
zinc pool.
In contrast to the marked expansion of mitochondrial Zn seen in
mitochondria isolated from m-Adh1
transformants cultured in standard
growth medium, the use of Zn-limiting conditions (synthetic culture
FIGURE 1. Mitochondrial zinc pools. Yeast cultures were grown in yeast peptone 1% dextrose (YP1D) medium medium prepared from Zn-defiand supplemented with 0 –200 M ZnCl2. Mitochondria were isolated from cultures in triplicate and analyzed
for zinc either from total or submitochondrial fractions by ICP-OES. Panel A, titration of supplemental zinc to cell cient nitrogen base) yielded mitocultures results in expansion of mitochondrial zinc. Panel B, soluble and pellet fractions were isolated from 0.5 chondria with a slight diminution
mg of mitochondria by sonication and centrifugation. Ion exchange using either CM-52 or DEAE-52 cellulose
in total mitochondrial Zn from
was used to separate cationic and anionic fractions respectively. Panel C, using the Zn-dependent fluorophore
Rhodzin-3, reactive zinc was assessed in mitochondrial lysate from 0.1 mg of mitochondria depleted of either m-Adh1-containing cells (Fig. 2E).
anionic or cationic Zn pools (post DEAE-52 or CM-52 binding, respectively; n ⫽ 4). Panels D–F, MonoS and MonoS chromatography of soluble
MonoQ ion exchange chromatography. Mitochondria were isolated from YP1D yeast cultures grown with 0.2
mM Zn (⫹Zn) or without (⫺Zn, Endogenous) and samples (equivalent to 0.5 mg of protein) were sonicated, lysates from these mitochondria
clarified, and boiled where indicated. Panel D, fractionation of soluble lysate using MonoS shows a single revealed a decrease in the cationic
cationic zinc peak that expands in response to zinc supplementation and is resistant to boiling. Panel E, either Zn component and corresponding
free Zn(II) in the form of ZnCl2 or previously purified mitochondrial cationic Zn were mixed with a 10-fold excess
of citrate and examined for the ability to bind to MonoS cation exchange resin. Panel F, fractionation of soluble increase in the Zn content of the
lysate using MonoQ anion exchange reveals a broad peak that expands modestly in response to zinc supple- unabsorbed wash fractions that
mentation, yet is not resistant to boiling. Panel G, gel filtration of the cationic zinc fraction isolated by MonoS
elutes on a G25 size exclusion column in a volume corresponding to salt. 280 nm absorbance for both bovine contained Adh1 immunoreactivity
serum albumin (BSA) and Vitamin B12 (B12) are shown. Volume exclusion (VE) and volume total (VT) are marked. (data not shown). Mitochondrial
lysates from either c-Adh1 or
m-Adh1 fusions as well as a control Adh1 construct lacking the m-Adh1 cells were incubated with RhodZin-3 under conditions
MTS (c-Adh1) were plated on Zn-limiting growth medium con- of equal total mitochondrial protein levels, and the lysates from
taining either glucose or glycerol in order to assess the effects of the m-Adh1 mitochondria showed a dramatic attenuation in
matrix targeted Adh1 (Fig. 2B). Cells harboring m-Adh1 and RhodZin-3 reactivity. Thus, the presence of m-Adh1 led to a
m-Adh1 (T48A) showed a growth impairment on glycerol/lactate marked shift of the RhodZin-3 reactive cationic Zn pool to Zn
medium and growth on this medium was enhanced by the inclu- associated with m-Adh1. These conditions correlate with the
sion of supplemental Zn(II) suggesting that the respiratory growth respiratory growth defect observed in Fig. 2B.
High-throughput Screen of Yeast Deletion Strains for Attenuimpairment was a Zn effect. To confirm the Zn effect, zrt1⌬ cells
lacking the high affinity Zn(II) permease Zrt1 were transformed ation in Labile Mitochondrial Zn—To identify proteins imporwith plasmids encoding either c-Adh1 or m-Adh1. The presence tant for maintenance of the labile zinc pool, we conducted two
of m-Adh1 in zrt1⌬ cells compromised respiratory growth with- high-throughput screens of yeast deletion mutants affecting
genes of known or predicted mitochondrial proteins. Of the 851
out requiring zinc-limiting culture medium (Fig. 2C).
JUNE 18, 2010 • VOLUME 285 • NUMBER 25
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iting, and this phenotype was suppressed by zinc supplements. In addition, the mzm1⌬ mutant grew poorly
at 37 °C in the absence of Zn limitation. These effects were largely suppressed by introduction of the
MZM1 gene on a plasmid (Fig. 3A).
However, growth of the mutant on
glycerol/lactate medium at 37 °C
was only partially restored by the
addition of supplemental zinc salts
indicating that exogenous zinc does
not completely restore the cell to a
normal state. Cells lacking Mzm1
also grew poorly when transformed
with an episomal vector expressing
m-Adh1 and cultured on glycerol/
lactate medium (Fig. 3B). The
growth impairment was observed
only in cells containing m-Adh1 and
not c-Adh1. Thus, mzm1⌬ mutants
grow poorly on respiratory carbon
sources when zinc is limiting and
this effect is reproduced by mitochondrial zinc depletion caused by
m-Adh1 expression.
The second high throughput
screen involved transforming the
684 deletion strains with a vector
encoding the catalytically inactive
T48A m-Adh1. Transformants were
serially diluted and plated on glucose and glycerol/lactate culture
FIGURE 2. Effect of matrix-targeted Adh1 (m-Adh1) on mitochondrial zinc. Upper panel A, a schematic medium. Thirty-five strains exhibitdepicting the N-terminal fusion of the Sod2 mitochondrial targeting sequence directing Adh1 to the matrix, ing a defect on glycerol/lactate only
where upon import the Sod2 presequence is removed. Lower panel A, relative expression of c-Adh1 and
m-Adh1 in both whole cell extracts and gradient-purified mitochondria relative to the respective loading in the presence of m-Adh1 (T48A)
controls Pgk1 and Por1. Panel B, wild-type yeast expressing either m-Adh1, or a catalytic inactive m-Adh1 were collected for subsequent analmutant (T48A), show respiratory phenotypes when grown under Zn-limited conditions that are suppressed in
ysis. Transformation was repeated
the presence of excess Zn. Panel C, yeast lacking the plasma membrane zinc transporter, Zrt1, show an m-Adh1induced respiratory phenotype without EDTA supplementation. Left panel D, total mitochondrial zinc from with the 35 candidate deletion
both c-Adh1- and m-Adh1-expressing cells obtained from cultures grown in synthetic complete Zn-replete strains using both m-Adh1 and
medium. Right panel D, MonoS fractionation and Rhodzin-3 fluorescence (n ⫽ 3) of soluble mitochondrial
lysates from either c-Adh1- or m-Adh1-expressing cultures. Left panel E, total mitochondrial zinc from both c-Adh1, and transformants were
c-Adh1- and m-Adh1-expressing cells obtained from cultures grown in synthetic complete Zn-deficient plated on medium in the presence
medium. Right panel E, MonoS fractionation and Rhodzin-3 fluorescence (n ⫽ 3) of soluble mitochondrial and absence of supplemental zinc.
lysates Zn-deficient cultures.
In addition to mzm1⌬ cells, we
identified six other mutant strains
total proteins in the mitochondrial proteome identified to date, that exhibited a reproducible growth impairment on glycerol/
684 are not essential for growth. These 684 viable mutant lactate medium in the presence of m-Adh1 but not c-Adh1 (Fig.
strains were arrayed in 96-well microtiter plates amenable to 4A). These included cit1⌬, mdh1⌬, mis1⌬, msb1⌬, nfu1⌬, and
tbs1⌬ cells. Limited rescue of the growth defect of certain transrobotic manipulations.
Initially, serial dilutions of the strains were performed roboti- formants was achieved by supplemental zinc. Mitochondria
cally and the cells were plated on Zn-limited culture medium purified from the six deletion strains were used for quantitation
(YP glycerol/lactate containing 0.4 mM EDTA). Ten deletion of total mitochondrial zinc by ICP-OES analysis and labile zinc
strains initially exhibited partial growth impairment on Zn-lim- by RhodZin-3 reactivity. Mitochondrial zinc was depressed in
ited glycerol/lactate medium. Of these, only one strain the cit1⌬, mdh1⌬, and tbs1⌬ cells and RhodZin-3 reactivity was
(YDR493W renamed mzm1⌬, Mzm1 designating mitochon- also attenuated in these strains with an especially marked
drial zinc maintenance) exhibited highly reproducible Zn- reduction in mdh1⌬ cells (Fig. 4B). Cit1 and Mdh1 are the citric
sensitive respiratory growth. The mzm1⌬ strain exhibited a acid cycle enzymes citrate synthase and malate dehydrogenase,
growth defect on glycerol/lactate medium when Zn(II) was lim- whereas Tbs1 is a large 1095-residue mitochondrial protein of
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W303 and BY4741 genetic backgrounds and the mzm1⌬ cells were
found to have a marked reduction in
the activity of Complex III (bc1)
measured either as succinate cytochrome c reductase activity or
ubiquinol cytochrome c reductase
activity (Fig. 7B). Complex IV (cytochrome c oxidase) activity was unaffected in the mzm1⌬ strain.
Impaired bc1 Complex Activity
Was Corroborated by Analysis of
the Respiratory Complexes—Dodecyl maltoside solubilization reduces
supercomplexes to individual complexes that can be separated by BNPAGE. Visualization of the bc1 complex using antibodies to three
separate subunits revealed its attenFIGURE 3. Zn-dependent respiratory defects. In a large-scale screen for mutants showing Zn-dependent uation in mzm1⌬ cells (Fig. 8A,
respiratory defects, we isolated mzm1⌬ from a collection of 684 deletion strains lacking proteins predicted to lanes 2, 4, 6). Despite disruption of
have mitochondrial localization. Panel A, mzm1⌬ cells are unable to grow on respiratory carbon sources under
Zn-limited conditions (EDTA) or at elevated temperature relative to both wild type and the complemented the assembled bc1 complex, the
steady-state levels of bc1 subunits
strain. Panel B, the presence of m-Adh1 severely restricts mzm1⌬ respiratory growth.
Cyt1 and Cor2 were not changed
unknown function. The marked respiratory defect of mzm1⌬ (Fig. 8B). However, a partial decrease in steady-state levels of
mutants in zinc-limited medium and that it was an un-anno- Rip1 was seen in mzm1⌬ cells. Although the bc1 complex abuntated ORF led us to focus our subsequent studies on the char- dance was diminished, no change was observed in either cytoacterization of Mzm1.
chrome c oxidase or ATP synthase complexes (Fig. 8A, lanes 8
Mzm1 Is Localized within the Mitochondrial Matrix—Mzm1 and 10, respectively). As expected from the decrease in the bc1
is a 13.9-kDa mitochondrial protein (21). The chromosomal complex, the abundance of bc1/cytochrome c oxidase superMZM1 was epitope tagged with Myc to generate a C-terminal complexes was significantly reduced in mzm1⌬ cells as
Myc-tagged protein. The tagged protein is functional and observed with digitonin solubilization (Fig. 8C, lanes 2 and 4).
retained in mitoplasts and was resistant to proteinase K in both No changes were evident in the monomeric and dimeric ATP
intact mitochondria and mitoplasts (Fig. 5A). The Mzm1 pro- synthase complexes (Complex V) (Fig. 8C, lanes 5 and 6).
tein was released by sonication of mitochondria suggesting it is Because mzm1⌬ cells show decreased matrix Zn(II), we tested
a soluble matrix protein (Fig. 5B). The exclusive mitochondrial whether zinc supplements would restore bc1 activity. Mutant
localization of Mzm1 was recently shown by an alpha comple- cells cultured in 200 M Zn(II) failed to restore bc1 activity (data
mentation test (22). Mzm1 is not part of a large protein com- not shown).
plex; the protein fractionates as a lower mass protein during
DISCUSSION
sucrose gradient centrifugation (Fig. 5C).
Mitochondrial Phenotypes of mzm1⌬ Cells—The growth
phenotypes of mzm1⌬ mutants suggest that zinc homeostasis
in mitochondria is disrupted. Consistent with this hypothesis,
mitochondria purified from mzm1⌬ cells have decreased Zn
content with no significant changes in iron, copper, manganese,
or magnesium levels (Fig. 6A, data not shown). The mutant cells
also show a marked decrease in RhodZin-3 reactivity consistent
with a diminished cationic Zn component (Fig. 6B). This was
corroborated by fractionation of mitochondrial lysates from
WT versus mzm1⌬ cells by ion exchange chromatography. The
anionic Zn fraction was not perturbed in mzm1⌬ cells (Fig. 6D),
but the cationic Zn fraction was greatly reduced (Fig. 6E).
As mentioned, mzm1⌬ cells are impaired for respiratory
growth at 37 °C and at 30 °C upon zinc limitation. To assess the
respiratory capacity of the mutant cells, oxygen consumption
was measured in WT and mutant cells (Fig. 7A). Total oxygen
consumption was reduced in the mutant cells at both 30 °C and
37 °C. Activities of Complexes III and IV were assessed in both
JUNE 18, 2010 • VOLUME 285 • NUMBER 25

We demonstrate for the first time that a bioavailable pool of
Zn(II) exists within the mitochondrial matrix that appears to be
critical for mitochondrial function. This pool can be titrated
out by expressing a matrix-targeted Zn-binding protein,
m-Adh1, in cells propagated in Zn-limiting medium. The labile
Zn(II) pool is ligand-bound and is cationic in nature. It is stable
in the presence of citrate as a competitor but is reactive with the
Zn-responsive fluorophore RhodZin-3. The matrix bioavailable Zn(II) pool increases in cells cultured with supplemental
Zn(II) salts in excess of 200 M. Current studies are underway
to structurally characterize this cationic Zn component.
The physiological significance of the matrix Zn(II) pool may
relate to either a detoxification mechanism for the metal or a
Zn(II) reservoir for metallation of Zn-binding proteins within
the matrix. Previous work demonstrated that the yeast vacuole
is the major reservoir of excess Zn(II) accumulated in cells cultured in high zinc (23–25). A marked expansion of the mitochondrial matrix zinc pool does not occur when the medium
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FIGURE 5. Localization of Mzm1. Panel A, mitochondria (100 g) expressing
Mzm1-Myc were kept intact (⫺ swell, lanes 1 and 2) or swollen (⫹ swell, lanes
3 and 4) and incubated with (lanes 2 and 4) or without (lanes 1 and 3) proteinase K (PK). The matrix marker protein is Aco1, mitochondrial aconitase; inner
mitochondrial space protein is Cyb2, cytochrome b2. Panel B, mitochondria
(100 g of protein) were fractionated using both hypotonic lysis (swelling)
and sonication. Pellet (P) and soluble (S) fractions were isolated by centrifugation (see “Materials and Methods” for details). In swollen mitoplasts in the
absence of sonication, Mzm1 and Aco1 are retained in the pellet fraction.
Detection with porin (Por1) antibody marks the pellet fraction. Panel C, mitochondria (1 mg) were solubilized in buffer containing 1% digitonin and centrifuged over a continuous 7–30% sucrose gradient. Mzm1-Myc migration is
shown relative to Por1 and markers for Complex III (Rip1), and for Complex IV
(Cox2).

FIGURE 4. m-Adh1-induced respiratory deficiency. Panel A, yeast mzm1⌬,
cit1⌬, mdh1⌬, mis1⌬, msb1⌬, nfu1⌬, and tbs1⌬ strains were identified as
m-Adh1 (T48A) sensitive from the collection of 684 strains lacking predicted
mitochondrial proteins. Strains were re-transformed with either c-Adh1 or
m-Adh1 (T48A) and grown in either synthetic complete (SC) glucose medium
without (⫺Zn) or with (⫹Zn) 500 M supplemental ZnCl2. Cultures were then
serially diluted onto SC medium agar with glucose or glycerol as carbon
sources. All strains were verified by PCR using a universal KanMX and genespecific primers. Panel B, mitochondria from cit1⌬, mdh1⌬, mis1⌬, msb1⌬,
nfu1⌬, and tbs1⌬ cells were purified from cells grown in standard SC 1%
glucose medium for comparison to wild-type mitochondria. Both total mitochondrial zinc and reactive zinc, as assessed with Rhodzin-3, were measured
in triplicate on three independent mitochondrial preparations.

zinc concentration is below 200 M. Detoxification of zinc
within the vacuole is efficient and mutations that disrupt vacuolar zinc storage render cells very sensitive to zinc toxicity.
Thus, the mitochondrial zinc pool is not likely to be a significant
mechanism of zinc detoxification.
The matrix Zn(II) pool appears important in mitochondrial
zinc metallation reactions. The plethora of Zn metalloenzymes
within mitochondria implies that a significant bioavailable
Zn(II) pool must exist for the metallation of these molecules
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upon their import. In support of this postulate is the observation that attenuation in the labile pool by the matrix-targeted
m-Adh1 correlates with impaired oxidative phosphorylation
and respiratory growth. The dominant negative effects of
m-Adh1 do not arise from perturbation in metabolism within
the matrix due to the catalytic activity of Adh1, because the
same effects are observed with a catalytically inactive matrix
Adh1. This suggests that Zn(II)-chelation is the likely cause of
the respiration defect. This is corroborated by two observations. First, the respiratory growth of cells harboring m-Adh1
are partially rescued in by supplemental zinc in the growth
medium, and second that m-Adh1 provokes respiratory deficiency in cells lacking the zinc importer, Zrt1. The dominant
negative effects of m-Adh1 are not observed in cells propagated
on zinc-sufficient standard culture medium. Under these culture conditions the presence of m-Adh1 results in an expansion
of mitochondrial Zn(II) corresponding to formation of
Zn-Adh1 and likely represents homeostatic regulation of the
labile zinc pool.
Metal ion transporters in the mitochondrial IM have been
identified for only Fe(II) ions. Transporters that mediate mitochondrial import of Zn(II), Mn(II), and Cu(I)/Cu(II) have not
been defined. In an attempt to identify proteins important for
mitochondrial import of Zn(II) or maintenance of the labile
Zn(II) pool, we conducted two different high throughput
screens. With a collection of yeast deletion strains of mitochondrial proteins, we screened for respiratory growth defects on
Zn-limiting medium and identified mzm1⌬ cells as sensitive to
Zn limitation.
Mzm1 is a mitochondrial matrix protein that not only influences the matrix cationic Zn pool but also has a role in the
assembly or stability of the bc1 complex. Cells lacking Mzm1
exhibited respiratory growth sensitivity to both Zn-limited
VOLUME 285 • NUMBER 25 • JUNE 18, 2010
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ciency suggesting a link between the
two phenotypes. However, supplemental zinc did not restore bc1 complex activity in the mutant cells.
This is consistent with the failure of
supplemental zinc to fully restore
glycerol growth of the mutant at
37 °C. Thus, Mzm1 may have other
roles and may affect zinc homeostasis indirectly.
The nature of the link between
zinc and the bc1 complex is not
obvious as none of the bc1 complex
subunits have known Zn-binding
proteins. However, the matrix-facing Cor1 and Cor2 bc1 subunits are
homologous to the MPP zinc-metalloproteinase (26, 27). MPP is a
dimeric proteinase with an HxxEH
Zn motif in one subunit. The core
FIGURE 6. Mitochondrial Zn defect in mzm1⌬ cells. Mitochondria were isolated for both WT and mzm1⌬ complex in the potato bc complex
1
from cells grown in yeast peptone 1% dextrose. Panel A, metal analysis of mitochondria (200 g; n ⫽ 3). Panel
B, mitochondria (50 g) were sonicated in 0.1 ml 10 mM Tris, and the clarified lysate incubated with Rhodzin-3 functions as the general MPP in that
to asses Zn-dependent fluorescence. Following fluorescent measurements, lysates were analyzed for metal species (28). However, vertebrate
content by ICP-OES (n ⫽ 3). Panel C, MonoS fractionation of mzm1⌬ soluble mitochondrial lysate. Panel D, bc core subunits have an altered
1
MonoQ fractionation of mzm1⌬ soluble mitochondrial lysate.
motif with a tyrosine replacing one
His residue (26). The yeast Cor1 and
Cor2 bc1 complex subunits lack the HXXEH motif, so it is
unlikely that a MPP-like function is conserved. A second link
between zinc and the bc1 complex is that the respiratory complex is inhibited by Zn(II) and two Zn(II) binding sites per monomer were mapped in the avian complex (27). The two sites are
spatially close to ubiquinone binding site.
Two other scenarios are envisioned for the observed zinc/
bc1 relationship. First, Mzm1 may have two distinct roles in
the maintenance of the matrix Zn pools and assembly/stability of the bc1 complex. Alternatively, the assembled bc1 complex may have a role in mitochondrial Zn import or efflux
such that cells impaired in bc1 formation may be compromised in mitochondrial zinc. A related link between a respiratory complex and mitochondrial metal pools was observed
with coa1⌬ and shy1⌬ cells. Both mutants are impaired in
the biogenesis of cytochrome c oxidase and in the maintenance of the matrix bioavailable Cu(I) pool (20, 29). Coa1
and Shy1 form complexes with newly synthesized Cox1 during its maturation and we postulated that these assembly
intermediates may also modulate import of Cu(I) across the
FIGURE 7. Respiratory defect in mzm1⌬ cells. Panel A, total oxygen consumption of mzm1⌬ relative to wild type at 30° and 37 °C. Panel B, analysis of IM. Whereas coa1⌬ and shy1⌬ cells are weakly suppressed
succinate cytochrome c reductase activity (Complex II/III), ubiquinol cyto- by supplemental copper in cultures, the respiratory defect of
chrome c reductase activity (Complex III), and cytochrome c oxidase activity
mzm1⌬ cells is not suppressed by supplemental zinc. Future
(Complex IV) using 10 –20 g of mitochondria per reaction (see “Materials
studies will focus on the role of Mzm1 in bc1 complex bioand Methods” for details) (n ⫽ 3 per assay).
genesis as well as matrix zinc maintenance.
medium and the presence of m-Adh1. The matrix cationic
The second screen was with the same collection of mutant
Zn(II) component was attenuated in mzm1⌬ cells in both strains transformed with a vector expressing matrix-targeted
W303 and BY4741 backgrounds as seen by MonoS chromatog- m-Adh1. Seven deletion mutants were observed to exhibit a
raphy and RhodZin-3 reactivity. In addition, mzm1⌬ cells have respiratory growth deficiency in the presence of m-Adh1 but
decreased accumulation of the dimeric bc1 complex. Reintro- not cytosolic c-Adh1. Although total mitochondrial zinc was
duction of the MZM1 gene into the mutant cells suppressed not markedly attenuated in most of these strains, RhodZin-3
both the mitochondrial zinc defect and the Complex III defi- reactivity of purified mitochondria was attenuated in several:
JUNE 18, 2010 • VOLUME 285 • NUMBER 25

JOURNAL OF BIOLOGICAL CHEMISTRY

19457

Mzm1 and Mitochondrial Zinc Homeostasis
natively, Mdh1 was recently shown
to associate with submicromolar
affinity with the bc1 complex via the
matrix-facing Cor1 and Cor2 subunits (30). This interaction was
shown to stimulate the bc1 activity
and enhance the reverse Mdh1 reaction thereby consuming oxaloacetate. Cells lacking Mdh1 were found
to be only modestly impaired in bc1
activity (⬃83% of wild type), so the
link of Zn and bc1 assembly remains
unclear. Nfu1 is one of three matrix
scaffold proteins for the assembly of
Fe/S clusters. Mis1 is a mitochondrial candidate C1-tetrahydrofolate
synthase (31). One-carbon transfer
reactions are mediated by tetrahydrofolate and derivatives of THF are
required for the biosynthesis of
purines, thymidylate, pantothenate,
and certain amino acids. C1-tetrahydrofolate synthases mediate
interconversion of different oxidation states of THF derivatives. Cells
lacking the cytosolic Ade3 C1-tetrahydrofolate synthase exhibit auxotrophies for adenine and histidine,
whereas cells lacking the mitochondrial Mis1 C1-tetrahydrofolate synthase lack an obvious effect on adenine or histidine biosynthesis or
respiration (31). Thus, Mis1 and
Ade3 have distinct functions and
the physiological significance of the
mitochondrial
Mis1
remains
unclear. Although Msb1 is a mitochondrial protein, it is implicated in
glucan synthesis and the Pkc1MAPK pathway (32). No clear mitochondrial function is known for
Msb1. No function is ascribed for
FIGURE 8. The bc1 complex is impaired in mzm1⌬ cells. Panel A, mitochondria (75 g) were solubilized in
buffer containing 1% dodecyl-␤-D-maltoside (DDM) and analyzed by BN-PAGE. Detection with Cyt1 (cyto- Tbs1 either. None of these molechrome c1, lanes 1 and 2), Rip1 (Rieske Iron-sulfur Protein 1, lanes 3 and 4), and Cor2 (core protein 2, lanes 5 and cules appear to be candidates for
6) reveal the state of dimeric Complex III (III2) in both WT and mzm1⌬. Detection of either Cox2 (lanes 7 and 8)
membrane Zn(II) transporters. The
or F1 (lanes 9 and 10) representing Complex IV and V, respectively, shows no defects between mzm1⌬ and
WT cells. Low molecular weight or free Cyt1 (F); low molecular weight or free Rip1 (F*); residual Complex identity of the mitochondrial Zn(II)
V signal (*). Panel B, immunoblot analysis of wild-type and mzm1⌬ cells for protein levels of Complex III transporter(s) remains unresolved.
subunits Rip1, Cyt1, and Cor2 as well as Cox2 (Complex IV) and porin. Panel C, mitochondria (150 g)
solubilized in buffer containing 1% digitonin were fractionated on a continuous 5–13% gradient gel and No transporter-encoding genes
protein analyzed by BN-PAGE. Detection with the Complex III subunit Cyt1 reveals subassembly com- were identified in our screens sugplexes (III*, and III**) together with dimeric Complex III (III2) and the higher Complex III/IV supercomplexes gesting that mitochondrial zinc
(III2/IV, and III2/IV2). Detection with the Complex IV component, Cox3, also reveals a Complex IV intermediate (IV*) in addition to dimeric Complex IV (IV2). Detection with the Complex V subunit, F1, reveals no transporters are either essential,
defect between mzm1⌬ and wild type.
and therefore would not be included
among the strains tested, or redunMzm1, Cit1, Mdh1, Nfu1, Mis1, Msb1, and Tbs1 were all found dant with other genes such that loss of one does not greatly alter
to contribute to the maintenance of the labile cationic Zn(II) mitochondrial zinc homeostasis.
pool. Cit1 and Mdh1 are citric acid cycle enzymes, so the depletion of these molecules will alter the levels of matrix metabolites Acknowledgments—We thank Dr. Amanda Bird for her gift of the
that may contribute to the cationic Zn(II)-component. Alter- Adh1 expression construct and Dr. Jared Rutter for participation in
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